Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ILC2s ride the Blimp to fly.

The Journal of experimental medicine·2026
Same author

Large neutral amino acid uptake and mTOR activation within CD4 T cells coordinate type 2 immunity and host resistance to <i>Trichuris muris</i>.

Discovery immunology·2026
Same author

The gut microbiome and metabolome associate with Schistosoma mansoni infection and cardiovascular disease risk in Uganda.

Nature communications·2026
Same author

An optimised faecal microRNA sequencing pipeline reveals fibrosis in Trichuris muris infection.

Nature communications·2025
Same author

A genome-scale metabolic model of parasitic whipworm.

Nature communications·2023
Same author

Amino acid availability acts as a metabolic rheostat to determine the magnitude of ILC2 responses.

The Journal of experimental medicine·2022

Related Experiment Video

Updated: Jun 15, 2026

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.8K

New Perspectives on Classical Alarmin Responses to Intestinal Helminth Infection.

Connor P Lynch1, Richard K Grencis1

  • 1The Lydia Becker Institute of Immunology and Inflammation and the Manchester Cell-Matrix Centre, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Parasite Immunology
|September 13, 2025
PubMed
Summary

Interleukins 33, 25, and thymic stromal lymphopoietin (TSLP) are key to type two immunity. Recent studies reveal non-epithelial alarmin production influencing immune responses at barrier sites.

Keywords:
alarmincell mediated immunityhelminthmucosal immunityparasite

More Related Videos

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products
12:40

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Published on: April 6, 2015

19.3K
A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
08:38

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

1.7K

Related Experiment Videos

Last Updated: Jun 15, 2026

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.8K
Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products
12:40

Cultivation of Heligmosomoides Polygyrus: An Immunomodulatory Nematode Parasite and its Secreted Products

Published on: April 6, 2015

19.3K
A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model
08:38

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

1.7K

Area of Science:

  • Immunology
  • Type 2 Immunity
  • Allergy Research

Background:

  • Interleukins 33, 25, and thymic stromal lymphopoietin (TSLP) are central to type two immune responses.
  • Helminth infection models have been extensively used to study these alarmins.
  • Questions persist regarding their cellular origins, targets, and immunomodulatory roles.

Purpose of the Study:

  • To review recent findings on alarmin-helminth interactions at barrier sites.
  • To discuss the implications for the conceptualization of alarmin responses.
  • To highlight non-epithelial alarmin production and its role in immune licensing.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of studies focusing on helminth infections and barrier immunity.
  • Synthesis of findings on alarmin cellular sources and immune recipients.

Main Results:

  • Non-epithelial cells are identified as significant sources of alarmins.
  • Alarmins primarily target lymphoid effector cells, not myeloid cells as previously thought.
  • Alarmins may license effector cell function in tissues during immune responses.

Conclusions:

  • Alarmin roles extend beyond classical epithelium-derived, myeloid-targeting paradigms.
  • Non-epithelial alarmin production shapes tissue immunity.
  • A revised conceptualization of alarmin responses is needed, particularly in the context of barrier immunity.